Thomas Jefferson University Sidney Kimmel Cancer Center — Philadelphia, Pennsylvania

Thomas Jefferson University Sidney Kimmel Cancer Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Thomas Jefferson University Sidney Kimmel Cancer Center has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia.

Sponsors: Center for International Blood and Marrow Transplant Research, Medivir, HiberCell, Inc..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Thomas Jefferson University Sidney Kimmel Cancer Center?

Thomas Jefferson University Sidney Kimmel Cancer Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Thomas Jefferson University Sidney Kimmel Cancer Center conducted?

Thomas Jefferson University Sidney Kimmel Cancer Center has 4 clinical trials on record, with 1 currently active. Their work covers Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia.

Is Thomas Jefferson University Sidney Kimmel Cancer Center accredited by Crixeo Health?

Yes — Thomas Jefferson University Sidney Kimmel Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Thomas Jefferson University Sidney Kimmel Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.